Jack Nathan Medical Corp.

TSXV:JNH Voorraadrapport

Marktkapitalisatie: CA$3.0m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Jack Nathan Medical Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Glenn Copeland

Algemeen directeur

CA$865.5k

Totale compensatie

Percentage CEO-salaris86.9%
Dienstverband CEO3.1yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.1yrs
Gemiddelde ambtstermijn bestuur4.1yrs

Recente managementupdates

Recent updates

Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Aug 12
Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jun 28
Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Feb 07
Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Oct 27
Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Dec 31
Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Analyse CEO-vergoeding

Hoe is Glenn Copeland's beloning veranderd ten opzichte van Jack Nathan Medical's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jul 31 2024n/an/a

-CA$9m

Apr 30 2024n/an/a

-CA$8m

Jan 31 2024CA$866kCA$752k

-CA$7m

Oct 31 2023n/an/a

-CA$8m

Jul 31 2023n/an/a

-CA$7m

Apr 30 2023n/an/a

-CA$6m

Jan 31 2023CA$831kCA$750k

-CA$7m

Oct 31 2022n/an/a

-CA$6m

Jul 31 2022n/an/a

-CA$7m

Apr 30 2022n/an/a

-CA$8m

Jan 31 2022CA$330kCA$229k

-CA$8m

Compensatie versus markt: De totale vergoeding ($USD 640.03K ) Glenn } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 176.73K ).

Compensatie versus inkomsten: De vergoeding van Glenn is gestegen terwijl het bedrijf verliesgevend is.

CEO

Glenn Copeland

3.1yrs

Tenure

CA$865,520

Compensatie

Dr. Glenn Copeland serves as Chief Medical Officer at Jack Nathan Medical Corp. since December 2020 and serves as its Chief Executive Officer since September 7, 2021 and serves as its President and also se...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Glenn Copeland
CEO, President3.1yrsCA$865.52kgeen gegevens
Michael Marchelletta
Co-Founder & Executive Vice-Chairman4.1yrsCA$52.50k24.36%
CA$ 742.6k
Marcy Herriman
Chief Operating Officer2.9yrsCA$293.62kgeen gegevens
Serge Cinelli
Chief Technology Officer4yrsgeen gegevensgeen gegevens
Jennifer Usher
Director of Marketing & Communicationsno datageen gegevensgeen gegevens

3.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van JNH wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Glenn Copeland
CEO, President1.8yrsCA$865.52kgeen gegevens
Michael Marchelletta
Co-Founder & Executive Vice-Chairman4.1yrsCA$52.50k24.36%
CA$ 742.6k
Blake Lyon
Independent Director4.1yrsCA$46.90kgeen gegevens
Anthony DeCristofaro
Independent Director4.1yrsCA$49.60kgeen gegevens
Mark Redinger
Independent Director1.3yrsCA$22.94kgeen gegevens

4.1yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van JNH wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).